Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-16

Clinical Trial Update: EMS-Initiated Buprenorphine

View source ↗

Summary

Update on a Yale University-sponsored trial evaluating EMS-initiated buprenorphine for opioid use disorder; the study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: Yale University | Conditions: Opioid Use Disorder | Status: NOT_YET_RECRUITING